搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aspergillus oryzae GPI ethanolamine phosphate transferase 2 (las21), partial CSB-YP650379DPA
CSB-EP650379DPA
CSB-BP650379DPA
CSB-MP650379DPA
CSB-EP650379DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Histone acetyltransferase type B subunit 2 (hat2) CSB-YP650380DPA
CSB-EP650380DPA
CSB-BP650380DPA
CSB-MP650380DPA
CSB-EP650380DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable pectinesterase A (pmeA) CSB-YP650381DPA
CSB-EP650381DPA
CSB-BP650381DPA
CSB-MP650381DPA
CSB-EP650381DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Nitrogen permease regulator 3 (npr3), partial CSB-YP650382DPA
CSB-EP650382DPA
CSB-BP650382DPA
CSB-MP650382DPA
CSB-EP650382DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Nucleolar protein 58 (nop58), partial CSB-YP650383DPA
CSB-EP650383DPA
CSB-BP650383DPA
CSB-MP650383DPA
CSB-EP650383DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Pentafunctional AROM polypeptide (aroM), partial CSB-YP650384DPA
CSB-EP650384DPA
CSB-BP650384DPA
CSB-MP650384DPA
CSB-EP650384DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Cytosolic Fe-S cluster assembly factor nbp35 (nbp35) CSB-YP650385DPA
CSB-EP650385DPA
CSB-BP650385DPA
CSB-MP650385DPA
CSB-EP650385DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Actin cytoskeleton-regulatory complex protein pan1 (pan1), partial CSB-YP650386DPA
CSB-EP650386DPA
CSB-BP650386DPA
CSB-MP650386DPA
CSB-EP650386DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Amino-acid acetyltransferase, mitochondrial (arg2) CSB-YP650387DPA
CSB-EP650387DPA
CSB-BP650387DPA
CSB-MP650387DPA
CSB-EP650387DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable rhamnogalacturonase C (rhgC) CSB-YP650388DPA
CSB-EP650388DPA
CSB-BP650388DPA
CSB-MP650388DPA
CSB-EP650388DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Protein transport protein sec13 (sec13) CSB-YP650389DPA
CSB-EP650389DPA
CSB-BP650389DPA
CSB-MP650389DPA
CSB-EP650389DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent RNA helicase ded1 (ded1), partial CSB-YP650390DPA
CSB-EP650390DPA
CSB-BP650390DPA
CSB-MP650390DPA
CSB-EP650390DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Transcription elongation factor spt5 (spt5), partial CSB-YP650391DPA
CSB-EP650391DPA
CSB-BP650391DPA
CSB-MP650391DPA
CSB-EP650391DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent RNA helicase dbp10 (dbp10), partial CSB-YP650392DPA
CSB-EP650392DPA
CSB-BP650392DPA
CSB-MP650392DPA
CSB-EP650392DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable endo-1,3 (4)-beta-glucanase AO090023000083 (AO090023000083), partial CSB-YP650393DPA
CSB-EP650393DPA
CSB-BP650393DPA
CSB-MP650393DPA
CSB-EP650393DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Kynureninase 2 (bna5-2) CSB-YP650394DPA
CSB-EP650394DPA
CSB-BP650394DPA
CSB-MP650394DPA
CSB-EP650394DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae NADH-cytochrome b5 reductase 2 (mcr1), partial CSB-YP650395DPA1
CSB-EP650395DPA1
CSB-BP650395DPA1
CSB-MP650395DPA1
CSB-EP650395DPA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Nucleolar protein 9 (nop9), partial CSB-YP650396DPA
CSB-EP650396DPA
CSB-BP650396DPA
CSB-MP650396DPA
CSB-EP650396DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mannosyl-oligosaccharide alpha-1,2-mannosidase 1B (mns1B) CSB-YP650397DPA
CSB-EP650397DPA
CSB-BP650397DPA
CSB-MP650397DPA
CSB-EP650397DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Serine/threonine-protein kinase ste20 (ste20), partial CSB-YP650398DPA
CSB-EP650398DPA
CSB-BP650398DPA
CSB-MP650398DPA
CSB-EP650398DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>